Over the last 12 months, one MedWellAI, Inc. the people running the company added shares in open-market trades, about $281,000 in total, and none of them sold.
Biggest single buyer: Rubakh Steve, CEO, with roughly $281,000. C-suite participation is part of the picture here.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 1 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Jun 18, 2026 | Rubakh Steve | CEO | Buy | 461,250 | $0.61 | $281K | SEC |
In the last 12 months MedWellAI, Inc. insiders made open-market purchases worth about $281,000 and sales worth about $0. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in MWAI was filed on 2026-06-18.
No congressional trades in MWAI were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).